145 related articles for article (PubMed ID: 15150133)
21. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
23. Recurrent malignant peripheral nerve sheath tumour in a patient with neurofibromatosis Type 1: a case report.
Dimou J; Jithoo R; Pitcher M; White G
J Clin Neurosci; 2009 Sep; 16(9):1221-3. PubMed ID: 19539475
[TBL] [Abstract][Full Text] [Related]
24. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
[TBL] [Abstract][Full Text] [Related]
25. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner RE; Gutmann DH
Cancer Res; 2002 Mar; 62(5):1573-7. PubMed ID: 11894862
[TBL] [Abstract][Full Text] [Related]
26. Malignant peripheral nerve sheath tumor of the vagus nerve in a teenager with the neurofibromatosis 1 gene mutation: a case report.
Sesenna E; Magri AS; Corradi D; Ferri T; Ferri A
J Pediatr Surg; 2011 Aug; 46(8):e9-12. PubMed ID: 21843710
[TBL] [Abstract][Full Text] [Related]
27. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
Agaimy A
Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
[TBL] [Abstract][Full Text] [Related]
28. JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors.
Shollar D; Del Valle L; Khalili K; Otte J; Gordon J
Oncogene; 2004 Jul; 23(32):5459-67. PubMed ID: 15133494
[TBL] [Abstract][Full Text] [Related]
29. Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome.
Pitchford CW; Schwartz HS; Atkinson JB; Cates JM
Am J Surg Pathol; 2006 Dec; 30(12):1624-9. PubMed ID: 17122521
[TBL] [Abstract][Full Text] [Related]
30. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.
Winter N; Rattay TW; Axer H; Schäffer E; Décard BF; Gugel I; Schuhmann M; Grimm A
Clin Neurophysiol; 2017 May; 128(5):702-706. PubMed ID: 28315612
[TBL] [Abstract][Full Text] [Related]
32. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient.
Molina AR; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542
[TBL] [Abstract][Full Text] [Related]
33. [Malignant peripheral nerve sheath tumor in the parotid gland developed on the basis of neurofibromatosis type 1].
Başaran B; Orhan KS; Polat B; Mete O; Başerer N
Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):220-4. PubMed ID: 21762053
[TBL] [Abstract][Full Text] [Related]
34. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis: part 2--clinical management.
Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
[TBL] [Abstract][Full Text] [Related]
36. [Von Recklinghausen's disease: experimental models and comparative aspects].
Turusov VS; Kardeza A; Ribal'ta T
Arkh Patol; 1996; 58(5):3-13. PubMed ID: 9005821
[TBL] [Abstract][Full Text] [Related]
37. Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.
Safaee MM; Lyon R; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Chin CT; Tihan T; Ames CP
J Neurosurg Spine; 2017 Jan; 26(1):103-111. PubMed ID: 27472744
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
39. [Nerve sheath tumours].
Le Guellec S
Ann Pathol; 2015 Jan; 35(1):54-70. PubMed ID: 25541115
[TBL] [Abstract][Full Text] [Related]
40. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
